ENALAPRIL Safety Questions, ENALAPRIL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ENALAPRIL. Our extensive database of ENALAPRIL adverse events and ENALAPRIL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ENALAPRIL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




ENALAPRIL Safety Reports

Total ENALAPRIL reports: 237.
ENALAPRIL FDA safety alerts: No.
Reported deaths: 21    Reported hospitalizations: 130.
Take ENALAPRIL Side Effects Survey or Share Your ENALAPRIL Story. Read More Here.

Showing 1-75 of 237 Next >

Health Professional from UNITED KINGDOM reported ENALAPRIL problem on Apr 23, 2007. Female patient, 76 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: anorexia, flatulence, nausea. ENALAPRIL dosage: 20 MG QD ORAL. During the same period patient was treated with CARDURA, BECLOMETHASONE DIPROPIONATE. Patient recovered.

ENALAPRIL problem was reported by a Health Professional from SPAIN on Apr 23, 2007. Male patient, 74 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hyponatraemia, inappropriate antidiuretic hormone secretion. ENALAPRIL dosage: unknown. During the same period patient was treated with AMLODIPINE MALEATE, DIGOXIN, ASPIRIN, RANITIDINE, LORMETAZEPAM, AMLODIPINE MALEATE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ENALAPRIL problem on May 14, 2007. Male patient, 25 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, swelling face, urticaria. ENALAPRIL dosage: 10 MG BID PO. During the same period patient was treated with ZANTAC, HYDROCHLOROTHIAZIDE. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from UNITED STATES on May 17, 2007. Male patient, 67 years of age, weighting 325.0 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: swollen tongue. ENALAPRIL dosage: 10MG TWICE DAILY PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SPAIN reported ENALAPRIL problem on May 07, 2007. Female patient, 42 years of age, weighting 121.3 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: vertigo. ENALAPRIL dosage: 20 MG, ORAL. Patient recovered.

ENALAPRIL problem was reported by a Health Professional from SWEDEN on May 02, 2007. Male patient, 54 years of age, was diagnosed with hypertension, obesity and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, neoplasm, renal cyst. ENALAPRIL dosage: (10 MG QD; ORAL). During the same period patient was treated with ACETAMINOPHEN, OMEGA, TIPAROL, DIOVAN. Patient recovered.

Physician from NETHERLANDS reported ENALAPRIL problem on May 04, 2007. Male patient, 43 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, condition aggravated, heart rate increased, treatment noncompliance. ENALAPRIL dosage: (10 MG BID ORAL). During the same period patient was treated with HYDROCHLOROTHIAZIDE, ATENOLOL, NIFEDIPINE. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from SWEDEN on May 03, 2007. Male patient, 84 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: eye inflammation, visual disturbance. ENALAPRIL dosage: 2.5 MG QD ORAL. During the same period patient was treated with LATANOPROST, TIMOLOL MALEATE. Patient recovered.

Physician from BELGIUM reported ENALAPRIL problem on May 03, 2007. Male patient, 79 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus. ENALAPRIL dosage: unknown. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from CANADA on May 03, 2007. Female patient, 51 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, hypersensitivity, nervousness, tachycardia. ENALAPRIL dosage: unknown. During the same period patient was treated with CLONAZEPAM, THYROID. Patient recovered.

Physician from BELGIUM reported ENALAPRIL problem on May 03, 2007. Male patient, 75 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: coronary artery disease, hypercholesterolaemia. ENALAPRIL dosage: unknown. Patient recovered.

ENALAPRIL problem was reported by a Health Professional from GERMANY on May 16, 2007. Female patient, 39 years of age, weighting 149.9 lb, was diagnosed with renal hypertension, nephrotic syndrome and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, colitis ulcerative, diarrhoea haemorrhagic, disease recurrence, haematochezia, haemoglobin decreased, ileitis, nephrotic syndrome. ENALAPRIL dosage: 2.5 MG DAILY. During the same period patient was treated with HYDROCHLOROTHIAZIDE, FUROSEMIDE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported ENALAPRIL problem on May 09, 2007. Male patient, 60 years of age, was diagnosed with hypertension, hyperlipidaemia and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: ventricular fibrillation. ENALAPRIL dosage: (10 MG QD ORAL). During the same period patient was treated with SIMVASTATIN. Patient died on 08/06/2005.

ENALAPRIL problem was reported by a Physician from INDIA on Nov 05, 2003. Male patient was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, congenital anomaly, neonatal anuria, oligohydramnios, peritoneal dialysis, premature baby, renal tubular disorder, skull malformation. ENALAPRIL dosage: MATERNAL DOSE (5 MG, MATERNAL DOSE). Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ENALAPRIL problem on May 31, 2007. Male patient, 62 years of age, was diagnosed with essential hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: dialysis, renal failure acute. ENALAPRIL dosage: 10MG DAILY PO. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Physician from INDIA on May 15, 2007. Female patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: foetal growth retardation, hydrops foetalis, neonatal disorder, renal failure, renal failure neonatal. ENALAPRIL dosage: 5 MG (5 MG, 1 IN 1 D). During the same period patient was treated with ANTIHYPERTENSIVES. Patient died.

Health Professional from SOUTH AFRICA reported ENALAPRIL problem on May 25, 2007. Male patient, 54 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, angioedema, anoxic encephalopathy, cardio-respiratory arrest, lip swelling, stridor, swollen tongue. ENALAPRIL dosage: unknown. During the same period patient was treated with ATENOLOL, THIAZIDES. Patient died.

ENALAPRIL problem was reported by a Consumer or non-health professional from MEXICO on May 21, 2007. Male patient, 53 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis. ENALAPRIL dosage: unknown. During the same period patient was treated with LOSARTAN POTASSIUM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported ENALAPRIL problem on May 22, 2007. Male patient, 60 years of age, was diagnosed with hypertension, hyperlipidaemia and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: ventricular fibrillation. ENALAPRIL dosage: (10 MG QD ORAL). During the same period patient was treated with SIMVASTATIN. Patient died on 08/06/2005.

ENALAPRIL problem was reported by a Physician from BELGIUM on May 24, 2007. Female patient, 43 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: coronary artery stenosis. ENALAPRIL dosage: unknown. During the same period patient was treated with BETA BLOCKING AGENTS, ASAFLOW, PLAVIX, DIURETICS, ZOCOR. Patient was hospitalized. Patient recovered.

Physician from NORWAY reported ENALAPRIL problem on May 29, 2007. Male patient, 76 years of age, was diagnosed with cardiac failure and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, angioedema, anoxic encephalopathy, asphyxia, respiratory arrest. ENALAPRIL dosage: unknown. Patient was hospitalized. Patient died on 02/27/2007.

ENALAPRIL problem was reported by a Consumer or non-health professional from FRANCE on May 30, 2007. Male patient, 60 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: inappropriate antidiuretic hormone secretion, viral myocarditis. ENALAPRIL dosage: 20 MG, QD. During the same period patient was treated with CYCLOSPORINE, PREDNISOLONE, OMEPRAZOLE. Patient recovered.

Physician from NETHERLANDS reported ENALAPRIL problem on May 31, 2007. Male patient, 43 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood albumin increased, blood pressure increased. ENALAPRIL dosage: 10 MG BID ORAL. During the same period patient was treated with NIFEDIPINE, HYDROCHLOROTHIAZDE, ATENOLOL. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Physician from SWITZERLAND on June 04, 2007. Male patient, 87 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium increased, dehydration, hypotension. ENALAPRIL dosage: (2.05 MG QD ORAL). During the same period patient was treated with TOREM, TENORMIN, ALDACTONE. Patient was hospitalized. Patient recovered.

Health Professional from SPAIN reported ENALAPRIL problem on June 11, 2007. Female patient, 69 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, inappropriate antidiuretic hormone secretion. ENALAPRIL dosage: 20 MG, QD. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Physician from FRANCE on June 11, 2007. Male patient, 41 years of age, was diagnosed with hypertension, renal transplant and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: affective disorder, cerebellar syndrome, convulsion, disturbance in attention, encephalopathy, hallucination, headache, lethargy, lyme disease. ENALAPRIL dosage: (20 MG QD ORAL). During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISOLONE, AMLODIPINE BESYLATE, CYCLOSPORINE, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ENALAPRIL problem on June 27, 2007. Female patient, 67 years of age, weighting 165.0 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: drooling, dyspnoea, erythema, local swelling, pharyngolaryngeal pain, swollen tongue, therapeutic response decreased. ENALAPRIL dosage: 20 MG DAILY PO NO ^RECENT^ DOSE CHANGE. During the same period patient was treated with LEVOTHYROXINE, SERTRALINE, CADUET, OMEPRAZOLE, NIFEREX, METFORMIN. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from UNITED STATES on July 06, 2006. Male patient, 59 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: swelling face. ENALAPRIL dosage: 5 MG BID PO. During the same period patient was treated with AMITIPTYLINE, CLINDAMYCIN, FLUNISOLIDE, GABAPENTIN, GUAIFENESIN DM, HYDROCHLOROTHIAZIDE, LORATADINE, METOPROLOL TARTRATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ENALAPRIL problem on July 05, 2006. Female patient was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, headache. ENALAPRIL dosage: 1 TAB 20 MGS 1 X A DAY. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from JAPAN on June 16, 2006. Male patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, hypoglycaemia, loss of consciousness. ENALAPRIL dosage: 5 MG Q DAY PO. During the same period patient was treated with SIGMART, GASMOTIN, ISOSORBIDE MONONITRATE, HERBESSER, THYRADIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ENALAPRIL problem on July 11, 2006. Male patient, 59 years of age, weighting 215.0 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, feeling abnormal. ENALAPRIL dosage: unknown. During the same period patient was treated with ZOCOR, ALLOPURINOL, ATENOLOL. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 21, 2006. Female patient, 60 years of age, was diagnosed with blood pressure increased and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, urticaria. ENALAPRIL dosage: 5 MG, ORAL. During the same period patient was treated with ATORVASTATIN CALCIUM, CODEINE PHOSPHATE, ACETAMINOPHEN, ACETAMINOPHEN W, QUININE SULPHATE. Patient recovered.

Consumer or non-health professional from SWEDEN reported ENALAPRIL problem on June 26, 2006. Male patient, 76 years of age, was diagnosed with cardiac disorder, diabetes mellitus and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hyperkalaemia, hypoglycaemia. ENALAPRIL dosage: 10 MG QD PO. During the same period patient was treated with GLYBURIDE, ALLOPURINOL, ASPIRIN, FUROSEMIDE, METOPROLOL SUCCINATE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Physician from ITALY on June 28, 2006. Female patient, 54 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate decreased, blood calcium increased, blood glucose increased, bradycardia, cardiac arrest, ill-defined disorder, pericardial effusion, pulmonary hypertension, radial pulse abnormal. ENALAPRIL dosage: unknown. During the same period patient was treated with VITAMIN B CAP. Patient died on 06/17/2006.

Physician from FRANCE reported ENALAPRIL problem on June 30, 2006. Male patient, 85 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, pseudolymphoma, pyrexia. ENALAPRIL dosage: unknown. During the same period patient was treated with ASPIRIN LYSINE, ETIFOXINE, LACTULOSE, TRIMETAZIDINE HYDROCHLORIDE, ZOPICLONE. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from ITALY on July 06, 2006. Male patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, bone disorder, osteoarthritis, osteomalacia, osteoporosis, rheumatoid arthritis, scoliosis. ENALAPRIL dosage: 20 MG. Patient recovered.

Health Professional from JAPAN reported ENALAPRIL problem on July 06, 2006. Male patient, 64 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blister, bronchostenosis, hypoaesthesia, musculoskeletal stiffness, pharyngolaryngeal pain. ENALAPRIL dosage: 5 MG Q DAY PO. Patient recovered.

ENALAPRIL problem was reported by a Physician from UNITED STATES on July 27, 2006. Female patient, 84 years of age, weighting 157.0 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, blood pressure increased, condition aggravated, pharmaceutical product counterfeit. ENALAPRIL dosage: 20 MG. Patient recovered.

Pharmacist from UNITED STATES reported ENALAPRIL problem on Aug 07, 2006. Male patient, 61 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: choking, dysphagia, dysphonia, infection, palatal oedema, pharyngolaryngeal pain, sensation of foreign body, uvulitis. ENALAPRIL dosage: 10 MG DAILY PO (DURATION: YEARS). During the same period patient was treated with LUNESTA, TRICOR, WELLBUTRIN, TROSPIUM, HUMALOG. Patient recovered.

ENALAPRIL problem was reported by a Physician from NORWAY on July 19, 2006. Female patient, 78 years of age, was diagnosed with hypertension, oedema and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood sodium increased, hyperkalaemia, renal failure acute. ENALAPRIL dosage: 10 MG QD; PO. During the same period patient was treated with SPIRIX, MADOPAR, CIPRAMIL, FLUNIPAM, REMERON, SOBRIL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ENALAPRIL problem on Aug 11, 2006. Male patient, weighting 374.6 lb, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, respiratory failure. ENALAPRIL dosage: 10MG BID PO. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from JAPAN on July 26, 2006. Male patient, 76 years of age, was diagnosed with hypertension, rhinitis allergic, constipation and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: anaemia, blood creatine phosphokinase increased, bowel sounds abnormal, bradycardia, cardiac murmur, cardiomegaly, constipation, electrocardiogram t wave amplitude decreased, heart rate irregular. ENALAPRIL dosage: 10 MG Q DAY. During the same period patient was treated with ENALAPRIL MALEATE, AREJIN, DAJOKANZO, NIFEDIPINE, FAMOTIDINE, BROTIZOLAM, TERAZOSIN. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported ENALAPRIL problem on July 27, 2006. Female patient, 78 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, bradycardia, electrocardiogram qt prolonged, electrocardiogram repolarisation abnormality, electrocardiogram t wave abnormal, hypokalaemia, malaise. ENALAPRIL dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, AMIODARONE, CELIPROLOL, FLUINDIONE. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from BULGARIA on May 02, 2006. Male patient, 59 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, erythrodermic psoriasis, hyperkeratosis, nail pitting, proteinuria, psoriatic arthropathy, skin exfoliation, tubulointerstitial nephritis. ENALAPRIL dosage: 10 MG, BID,. Patient was hospitalized. Patient recovered.

Physician from ITALY reported ENALAPRIL problem on Aug 16, 2006. Female patient, 61 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood pressure increased, dialysis, headache, infection, nausea, renal impairment. ENALAPRIL dosage: 20 MG QD PO. During the same period patient was treated with ENALAPRIL MALEATE, AMLODIPINE BESYLATE, CALCITRIOL, CARVEDILOL, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, NIFEDIPINE. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 25, 2006. Female patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: fall. ENALAPRIL dosage: unknown. During the same period patient was treated with FELODIPINE, BECLOMETHASONE DIPROPIONATE, ACETAMINOPHEN, SALBUTAMOL. Patient recovered.

Consumer or non-health professional from CHILE reported ENALAPRIL problem on Sept 04, 2006. Female patient, 50 years of age, was diagnosed with hypertension, pain and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: cerebral infarction. ENALAPRIL dosage: unknown. During the same period patient was treated with ZELMAC. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 24, 2006. Female patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: fall. ENALAPRIL dosage: unknown. During the same period patient was treated with FELODIPINE, ACETAMINOPHEN, ALBUTEROL, BECLOMETHASONE DIPROPIONATE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported ENALAPRIL problem on Aug 28, 2006. Male patient, 79 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, lung infection, neutropenia, renal failure. ENALAPRIL dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, HEPARIN, ANTIBIOTIC, CITALOPRAM HYDROBROMIDE, FLUINDIONE, FOLIC ACID, FUROSEMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from UNITED STATES on Sept 14, 2006. Male patient, 70 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. ENALAPRIL dosage: 40MG PO BID. During the same period patient was treated with SPIRONOLACTONE, ACETAMINOPHEN, ATENOLOL, ENALAPRIL MALEATE, FUROSEMIDE, LASIX, GOSERELIN ACETATE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ENALAPRIL problem on Sept 14, 2006. Male patient, 49 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, swelling face. ENALAPRIL dosage: 20 MG PO BID. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 24, 2006. Female patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: fall. ENALAPRIL dosage: unknown. During the same period patient was treated with FELODIPINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ENALAPRIL problem on Sept 21, 2006. Male patient, 74 years of age, weighting 143.0 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema. ENALAPRIL dosage: 5 MG Q DAY PO. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, 75 years of age, was diagnosed with systolic hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, feeling abnormal, heart rate increased. ENALAPRIL dosage: 10 MG OR 15 MG ONCE DAILY, ORAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CHILE reported ENALAPRIL problem on Sept 04, 2006. Female patient, 50 years of age, was diagnosed with hypertension, irritable bowel syndrome and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: aortic thrombosis, cerebral infarction. ENALAPRIL dosage: unknown. During the same period patient was treated with ZELMAC. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Physician from SWEDEN on Sept 05, 2006. Male patient, 62 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: retinopathy, vision blurred. ENALAPRIL dosage: 20 MG QD PO. Patient recovered.

Health Professional from UNITED KINGDOM reported ENALAPRIL problem on Aug 29, 2006. Female patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: fall. ENALAPRIL dosage: unknown. During the same period patient was treated with FELODIPINE, BECLOMETHASONE DIPROPIONATE, ACETAMINOPHEN, SALBUTAMOL BP. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from UNITED STATES on Sept 28, 2006. Female patient, 55 years of age, weighting 212.0 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, oedema mouth, paraesthesia, pharyngeal oedema, swelling face, swollen tongue. ENALAPRIL dosage: 20 MG BID PO. During the same period patient was treated with NORVASC, AMARYL, METFORMIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ENALAPRIL problem on Sept 13, 2006. Male patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, viral infection. ENALAPRIL dosage: unknown. During the same period patient was treated with VYTORIN, DIGOXIN, INSPRA, COREG, FUROSEMIDE, POTASSIUM CHLORIDE, METFORMIN, ASPIRIN. Patient recovered.

ENALAPRIL problem was reported by a Physician from UNITED STATES on Sept 14, 2006. Female patient, 61 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: completed suicide, incorrect dose administered. ENALAPRIL dosage: unknown. During the same period patient was treated with VALPROIC ACID, ACETAMINOPHEN. Patient died.

Consumer or non-health professional from BRAZIL reported ENALAPRIL problem on Sept 15, 2006. Female patient, 30 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: chest pain, nausea, neck pain, palpitations. ENALAPRIL dosage: 40 MG UNK; PO. During the same period patient was treated with NIFEDIPINE. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Physician from NORWAY on Sept 15, 2006. Female patient, 65 years of age, was diagnosed with urinary tract infection and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree, atrioventricular block third degree, blood creatinine increased, hyperkalaemia, nodal rhythm. ENALAPRIL dosage: unknown. During the same period patient was treated with SANDIMMUNE, TRIMETHOPRIM, NORVASC, ALBYL, LESCOL, NOVORAPID, INSULATARD NPH, MONOKET. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported ENALAPRIL problem on Sept 18, 2006. Female patient, 70 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: asthenia, hyperkalaemia, metabolic acidosis, muscular weakness, renal failure acute. ENALAPRIL dosage: 20 MG PO. During the same period patient was treated with SPIRONOLACTONE, ASPIRIN, CELIPROLOL, FUROSEMIDE, METFORMIN, NICARDIPINE. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Health Professional from UNITED STATES on Oct 10, 2006. Male patient, weighting 176.0 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, muscle spasms, rash. ENALAPRIL dosage: 10 MG QD PO. During the same period patient was treated with VALIUM, DURAGESIC, PLAVIX, ALLEGRA, CALTRATE, PREVACID, NITROGLYCERIN, MEGACE. Patient recovered.

Consumer or non-health professional from BRAZIL reported ENALAPRIL problem on Sept 25, 2006. Male patient, 51 years of age, was diagnosed with blood cholesterol and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, chest pain, headache. ENALAPRIL dosage: 10 MG BID; PO. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from UNITED STATES on Oct 13, 2006. Male patient, 63 years of age, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema. ENALAPRIL dosage: unknown. Patient recovered.

Health Professional from NETHERLANDS reported ENALAPRIL problem on Sept 27, 2006. Female patient, 86 years of age, was diagnosed with urinary tract infection and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, pneumonia, respiratory failure. ENALAPRIL dosage: 10 MG QD PO. During the same period patient was treated with NITROFURANTOIN, ASPIRIN, FUROSEMIDE, TAMOXIFEN CITRATE. Patient was hospitalized. Patient died.

ENALAPRIL problem was reported by a Physician from FRANCE on Sept 28, 2006. Male patient, 57 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood urea increased, dehydration, diarrhoea, electrocardiogram t wave peaked, hyperkalaemia, hyponatraemia. ENALAPRIL dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, ASPIRIN, ATAZANAVIR SULPHATE, ENALAPRIL MALEATE W, FELODIPINE, FUROSEMIDE, RIBOFLAVIN TETRABUTYRATE, RITONAVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ENALAPRIL problem on Oct 04, 2006. Male patient was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: no adverse effect. ENALAPRIL dosage: unknown. Patient recovered.

ENALAPRIL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 06, 2006. Male patient, 86 years of age, weighting 160.9 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: wheezing. ENALAPRIL dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, BENDROFLUAZIDE, MINOXIDIL. Patient recovered.

Health Professional from UNITED KINGDOM reported ENALAPRIL problem on Oct 05, 2006. Male patient, 86 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: wheezing. ENALAPRIL dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, ATORVASTATIN CALCIUM, BENDROFLUMETHIAZIDE, MINOXIDIL. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from UNITED STATES on Oct 25, 2006. Male patient, 64 years of age, weighting 265.0 lb, was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: chest pain, dizziness, hypotension. ENALAPRIL dosage: 5MG PO BID. During the same period patient was treated with METOPROLOL TARTRATE, ISOSORBIDE MONONITRATE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported ENALAPRIL problem on Oct 17, 2006. Male patient, 65 years of age, was diagnosed with cardiac failure congestive, hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: blood ph decreased, creatinine renal clearance decreased, dehydration, hyperkalaemia, renal failure acute. ENALAPRIL dosage: 10 MG BID PO. During the same period patient was treated with ENALAPRIL MALEATE, SPIRONOLACTONE, FUROSEMIDE, BISOPROLOL FUMARATE, BUFLOMEDIL, ESOMEPRAZOLE MAGNESIUM. Patient was hospitalized. Patient recovered.

ENALAPRIL problem was reported by a Pharmacist from UNITED STATES on Nov 07, 2006. Female patient, 52 years of age, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, chest discomfort, dysphagia, dyspnoea, pruritus, rash. ENALAPRIL dosage: 20MG DAILY PO. During the same period patient was treated with LEVOTHYROXINE, HYDROCHLOROTHIAZIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ENALAPRIL problem on Nov 14, 2006. Male patient, 71 years of age, weighting 148.0 lb, was diagnosed with hypertension and was treated with ENALAPRIL. After drug was administered, patient experienced the following problems/side effects: polymyalgia rheumatica. ENALAPRIL dosage: 5MG 1 DAILY PO. During the same period patient was treated with PROSCAR, TERAZOCIN. Patient recovered.

Showing 1-75 of 237 Next >

Ask Our Patient Community about ENALAPRIL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl ester